Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Olopatadine Hydrochloride Tablets

Approval Number

国药准字H20223262

Company四川子仁制药有限公司

Registration Date

April 27, 2022

Drug Information

Generic Name

盐酸奥洛他定片

Dosage Form

片剂

Strength

5mg

Drug Type

化学药品

Registration Date

April 27, 2022

Company Information

Applicant Company

Company Name四川子仁制药有限公司

Company Address

四川省德阳市广汉市深圳路西二段3号

Manufacturing Company

Company Name四川子仁制药有限公司

Company Address

四川省德阳市广汉市深圳路西二段3号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy